纳特拉基因检测 NTRA
$310.67 −$53.09 (-14.59%)
休市 · Nov 6, 8:20 pm ET · 最新盘后价 $311.20 +0.17%
开盘$319.99
昨收$363.76
当日区间$304.00 – $327.53
成交量5.78M
市值$45.05B
市盈率（TTM）–
股息率–
财报
财报日平均波动±9.8%近16次财报
收涨次数10 / 1663% 的概率
最佳反应+21.4%
最差反应-12.7%
每次财报后次日股价变动
| 季度 | 财报日期 | 时段 | 隐含波动 | 实际波动 | 较隐含波动 |
|---|---|---|---|---|---|
| 2026/Q2 | 6 Aug 2026 | After Market | ±9.9% | +21.37% | 超出定价预期 |
| 2026/Q1 | 7 May 2026 | After Market | ±11.6% | -11.64% | 超出定价预期 |
| 2025/Q4 | 26 Feb 2026 | After Market | ±10.7% | -3.73% | 符合区间 |
| 2025/Q3 | 6 Nov 2025 | After Market | ±10.3% | +0.55% | 符合区间 |
| 2025/Q2 | 7 Aug 2025 | After Market | ±12.7% | +7.70% | 符合区间 |
| 2025/Q1 | 8 May 2025 | After Market | ±12.1% | -6.53% | 符合区间 |
| 2024/Q4 | 27 Feb 2025 | After Market | ±16.7% | -0.65% | 符合区间 |
| 2024/Q3 | 12 Nov 2024 | After Market | ±15.4% | +19.13% | 超出定价预期 |
| 2024/Q2 | 8 Aug 2024 | After Market | ±15.2% | +6.38% | 符合区间 |
| 2024/Q1 | 9 May 2024 | After Market | ±12.7% | +10.19% | 符合区间 |
| 2023/Q4 | 28 Feb 2024 | After Market | ±10.6% | +12.99% | 超出定价预期 |
| 2023/Q3 | 8 Nov 2023 | After Market | ±15.6% | +9.80% | 符合区间 |
| 2023/Q2 | 3 Aug 2023 | After Market | ±12.1% | +17.56% | 超出定价预期 |
| 2023/Q1 | 9 May 2023 | After Market | ±10.8% | -3.38% | 符合区间 |
| 2022/Q4 | 28 Feb 2023 | After Market | ±17.2% | +11.80% | 符合区间 |
| 2022/Q3 | 8 Nov 2022 | After Market | ±14.3% | -12.65% | 符合区间 |
"隐含波动"指财报发布前期权市场定价的预期波幅。"波动"指财报发布后首个交易日的股价变化。
基本面
最新报告季度：Q2, ended Jun 2026
营收$752.75M+37.7% YoY
营业利润-$75.79M+31.3% YoY
净利润-$66.97M+33.7% YoY
摊薄每股收益-$0.47+36.5% YoY
自由现金流-$8.64M-174.0% YoY
经营现金流$54.79M
营收，近8个季度
净利润，近8个季度
盈利能力与资产负债表
毛利率65.2%
营业利润率-10.7%
净利率-7.1%
净资产收益率-12.5%
资产收益率-8.7%
投入资本回报率-12.6%
流动比率3.00
负债/资产比率31.5%
现金及投资$1.09B
总负债$223.37M
净现金（净负债）$868.14M
自由现金流/营收1.9%
暂无评论——快来第一个聊聊 NTRA。
登录后参与讨论。